Cellphire Therapeutics
PrivateLast Round
Series A
Apr 2, 2021
Total Funding Raised
$104.25M
Company Overview
Cellphire Therapeutics is a clinical-stage biotechnology company that develops next-generation platelet-derived therapeutics to treat hemorrhaging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Defense Tech, Pharma Supply Chain
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellphire Therapeutics Comparables
Compare Cellphire Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Haima Therapeutics | 81% | |
| Cayuga Biotech | 73% | |
| Velico Medical | 72% | |
Cellphire Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 2, 2021 | ||||
| Grant | Jan 15, 2020 | ||||
| Early Funding | Jun 5, 2017 | ||||
| VC Round | Jun 10, 2014 |
Cellphire Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | VC Round |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| U.S. Army Medical Research Acquisition Activity | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors increased 37% MoM, reaching 1.6K.
- Apr 2, 2021
$15M round completed.
Cellphire Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellphire Therapeutics's valuation, stock price, and market status.